Pharmacotherapy reduces conduction system disease risk

Lisinopril therapy significantly reduces incident conduction system disease, indicates a post-hoc analysis of ALLHAT data.
Source: MedWire News - Category: Consumer Health News Tags: Arrhythmia Source Type: news